J&J shareholders approve CEO Gorsky's near $30 million pay plan
Reuters
Published Apr 22, 2021 11:49AM ET
By Jessica DiNapoli
NEW YORK (Reuters) - Shareholders at Johnson & Johnson (NYSE:JNJ) approved Chief Executive Alex Gorsky's $29.6 million pay plan for 2020 at the healthcare company's annual general meeting on Thursday.
J&J's pay plan has been scrutinized by some investors because it excluded from its calculation of stock awards to its top executives some $9 billion in costs related to thousands of lawsuits claiming it helped fuel the U.S. opioid crisis and that traces of asbestos in its talc baby powder caused cancer. J&J has said the move is consistent with its long-term practices.
The final results of the vote, including the total number of J&J investors who approved and rejected the pay arrangement, will be released in the coming days.
Gorsky also answered a question from an investor on the possible link between J&J's COVID-19 vaccine and a very rare but serious blood clot condition that led to a U.S. pause in its use.
He said the company was looking forward to a U.S. regulatory meeting and review of the issue scheduled for Friday
"We strongly support awareness of the signs and symptoms of this extremely rare event to ensure the correct diagnosis, appropriate treatment and expedited reporting by healthcare professionals," Gorsky said. "We continue to believe in the positive benefit-risk profile of our vaccine."
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.